2Ott K,Lordick F,Blank S,et al.Gastric cancer:surgery in 2011[J].Langenbeck's Archives of Surgery,2011,396(6):743-758.
3Siewert JR,Stein HJ.Classification of carcinoma of the esophagogastric junction[J].Br J Surg,1998,85(11):1457-1459.
4Stahl M,Walz MK,Stuschke M,et al.Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction[J].J Clin Oncol,2009,27(6):851-856.
5Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors[J].Breast Cancer,2005,12(1),S16-S27.
6Trotti A,Colevas AD,Setser A,et al.CTCAE v3.0,development of a comprehensive grading system for the adverse effects of cancer treatment[J].Semin Radiat Oncol,2003,13(3):176-181.
7Saito H,Osaki T,Murakami D,et al.Effect of age on prognosis in patients with gastric cancer[J].ANZ J Surg,2006,76(6):458461.
9Macdonald JS.Smalley SR.Benedetti J,et al.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction[J].N Engl J Med,2001,345(10):725-730.
10Japanese Gastric Cancer Association.Japanese gastric cancer treatment guidelines 2010(ver.3)[J].Gastric Cancer,2011,14(2):113-123.
